| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,175 |
13,720 |
$3.39M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,816 |
5,508 |
$2.04M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
942 |
929 |
$250K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,850 |
1,726 |
$73K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
242 |
236 |
$70K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,808 |
3,579 |
$64K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,209 |
4,107 |
$54K |
| 55180 |
|
32 |
32 |
$47K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,210 |
3,929 |
$44K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,440 |
2,235 |
$37K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
193 |
183 |
$37K |
| 85027 |
|
6,041 |
5,580 |
$30K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,659 |
2,522 |
$28K |
| 71045 |
Radiologic examination, chest; single view |
1,445 |
1,364 |
$24K |
| 81003 |
|
4,930 |
4,696 |
$15K |
| 80053 |
Comprehensive metabolic panel |
1,054 |
967 |
$14K |
| 80076 |
|
1,341 |
1,304 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
329 |
321 |
$8K |
| 84702 |
|
920 |
852 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
689 |
672 |
$5K |
| 84484 |
|
912 |
772 |
$4K |
| 87081 |
|
494 |
488 |
$4K |
| 54300 |
|
12 |
12 |
$4K |
| 83690 |
|
828 |
790 |
$4K |
| 81025 |
|
501 |
480 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
385 |
351 |
$2K |
| 14040 |
|
12 |
12 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
12 |
$2K |
| 87420 |
|
206 |
206 |
$2K |
| 54161 |
|
13 |
13 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
149 |
141 |
$796.82 |
| 82248 |
|
206 |
195 |
$594.22 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
15 |
15 |
$417.82 |
| 70450 |
Computed tomography, head or brain; without contrast material |
12 |
12 |
$340.20 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$181.99 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
26 |
$100.66 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$56.59 |
| 85730 |
|
42 |
40 |
$47.35 |
| 85610 |
|
55 |
53 |
$46.12 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
28 |
26 |
$45.20 |
| 86900 |
|
27 |
24 |
$26.53 |
| 86901 |
|
27 |
24 |
$26.53 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
12 |
$17.21 |
| 85049 |
|
12 |
12 |
$12.06 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
78 |
$9.32 |
| 83735 |
|
14 |
12 |
$9.01 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
13 |
$7.46 |
| 85014 |
|
12 |
12 |
$6.38 |
| 85018 |
|
12 |
12 |
$6.38 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| A9270 |
Non-covered item or service |
182 |
77 |
$0.00 |